Normal view MARC view ISBD view

Primary care system-level training and support programme for the secondary prevention of domestic violence and abuse : a cost-effectiveness feasibility model Madeleine Cochrane, Eszter Szilassy, Caroline Coope, Elizabeth Emsley, Medina Johnson, Gene Feder and Estela Capelas Barbosa

By: Cochrane, Madeleine.
Contributor(s): Szilassy, Eszter | Coope, Caroline | Emsley, Elizabeth | Johnson, Medina | Feder, Gene | Barbosa, Estela C.
Material type: materialTypeLabelArticleSeries: BMJ Open.Publisher: BMJ, 2024Subject(s): DOMESTIC VIOLENCE | ECONOMIC ASPECTS | INTERVENTION | HEALTH | INTIMATE PARTNER VIOLENCE | INTERNATIONAL | UNITED KINGDOMOnline resources: DOI: 10.1136/bmjopen-2022-071300 (Open access) In: BMJ Open, 2024: 14 :e071300Summary: Objectives This study aimed to evaluate the prospective cost-effectiveness of the Identification and Referral to Improve Safety plus (IRIS+) intervention compared with usual care using feasibility data derived from seven UK general practice sites. Method A cost–utility analysis was conducted to assess the potential cost-effectiveness of IRIS+, an enhanced model of the UK’s usual care. IRIS+ assisted primary care staff in identifying, documenting and referring not only women, but also men and children who may have experienced domestic violence/abuse as victims, perpetrators or both. A perpetrator group programme was not part of the intervention per se but was linked to the IRIS+ intervention via a referral pathway and signposting. A Markov model was constructed from a societal perspective to estimate mean incremental costs and quality-adjusted life years (QALYs) of IRIS+ compared with to usual care over a 10-year time horizon. Results The IRIS+ intervention saved £92 per patient and produced QALY gains of 0.003. The incremental net monetary benefit was positive (£145) and the IRIS+ intervention was cost-effective in 55% of simulations at a cost-effectiveness threshold of £20 000 per QALY. Conclusion The IRIS+ intervention could be cost-effective or even cost saving from a societal perspective in the UK, though there are large uncertainties, reflected in the confidence intervals and simulation results. (Authors' abstract). Record #8491
Item type Current location Call number Status Date due Barcode
Access online Access online Family Violence library
Online Available ON24010019

BMJ Open, 2024: 14 :e071300.

Objectives This study aimed to evaluate the prospective cost-effectiveness of the Identification and Referral to Improve Safety plus (IRIS+) intervention compared with usual care using feasibility data derived from seven UK general practice sites.

Method A cost–utility analysis was conducted to assess the potential cost-effectiveness of IRIS+, an enhanced model of the UK’s usual care. IRIS+ assisted primary care staff in identifying, documenting and referring not only women, but also men and children who may have experienced domestic violence/abuse as victims, perpetrators or both. A perpetrator group programme was not part of the intervention per se but was linked to the IRIS+ intervention via a referral pathway and signposting. A Markov model was constructed from a societal perspective to estimate mean incremental costs and quality-adjusted life years (QALYs) of IRIS+ compared with to usual care over a 10-year time horizon.

Results The IRIS+ intervention saved £92 per patient and produced QALY gains of 0.003. The incremental net monetary benefit was positive (£145) and the IRIS+ intervention was cost-effective in 55% of simulations at a cost-effectiveness threshold of £20 000 per QALY.

Conclusion The IRIS+ intervention could be cost-effective or even cost saving from a societal perspective in the UK, though there are large uncertainties, reflected in the confidence intervals and simulation results. (Authors' abstract). Record #8491